BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 20953557)

  • 1. miR-126 and miR-126*: new players in cancer.
    Meister J; Schmidt MHH
    ScientificWorldJournal; 2010 Oct; 10():2090-100. PubMed ID: 20953557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis.
    Hong G; Kuek V; Shi J; Zhou L; Han X; He W; Tickner J; Qiu H; Wei Q; Xu J
    J Cell Physiol; 2018 Nov; 233(11):8526-8537. PubMed ID: 29923200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells.
    Musiyenko A; Bitko V; Barik S
    J Mol Med (Berl); 2008 Mar; 86(3):313-22. PubMed ID: 18193184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells.
    Saito Y; Friedman JM; Chihara Y; Egger G; Chuang JC; Liang G
    Biochem Biophys Res Commun; 2009 Feb; 379(3):726-31. PubMed ID: 19116145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7.
    Sun Y; Bai Y; Zhang F; Wang Y; Guo Y; Guo L
    Biochem Biophys Res Commun; 2010 Jan; 391(3):1483-9. PubMed ID: 20034472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressive effect of microRNA-126 on oral squamous cell carcinoma in vitro.
    Yang X; Wu H; Ling T
    Mol Med Rep; 2014 Jul; 10(1):125-30. PubMed ID: 24789258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer.
    Zhang Y; Wang X; Xu B; Wang B; Wang Z; Liang Y; Zhou J; Hu J; Jiang B
    Oncol Rep; 2013 Oct; 30(4):1976-84. PubMed ID: 23900443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-126 inhibits tube formation of HUVECs by interacting with EGFL7 and down-regulating PI3K/AKT signaling pathway.
    Li Q; Cheng K; Wang AY; Xu QG; Fu ZF; He SY; Xu PX
    Biomed Pharmacother; 2019 Aug; 116():109007. PubMed ID: 31170663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-383 inhibits proliferation, migration and angiogenesis of glioma-exposed endothelial cells in vitro via VEGF-mediated FAK and Src signaling pathways.
    Zhao LN; Wang P; Liu YH; Cai H; Ma J; Liu LB; Xi Z; Li ZQ; Liu XB; Xue YX
    Cell Signal; 2017 Jan; 30():142-153. PubMed ID: 27693218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
    Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
    Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2.
    Zhu N; Zhang D; Xie H; Zhou Z; Chen H; Hu T; Bai Y; Shen Y; Yuan W; Jing Q; Qin Y
    Mol Cell Biochem; 2011 May; 351(1-2):157-64. PubMed ID: 21249429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-23a-3p is a Key Regulator of IL-17C-Induced Tumor Angiogenesis in Colorectal Cancer.
    Lee Y; Kim SJ; Choo J; Heo G; Yoo JW; Jung Y; Rhee SH; Im E
    Cells; 2020 Jun; 9(6):. PubMed ID: 32492770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
    Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö
    J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ets-1 and Ets-2 regulate the expression of microRNA-126 in endothelial cells.
    Harris TA; Yamakuchi M; Kondo M; Oettgen P; Lowenstein CJ
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1990-7. PubMed ID: 20671229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation-associated Silencing of microRNA-126 and its Host Gene EGFL7 in Malignant Pleural Mesothelioma.
    Andersen M; Trapani D; Ravn J; Sørensen JB; Andersen CB; Grauslund M; Santoni-Rugiu E
    Anticancer Res; 2015 Nov; 35(11):6223-9. PubMed ID: 26504055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis.
    Wang S; Aurora AB; Johnson BA; Qi X; McAnally J; Hill JA; Richardson JA; Bassel-Duby R; Olson EN
    Dev Cell; 2008 Aug; 15(2):261-71. PubMed ID: 18694565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-193: A new weapon against cancer.
    Khordadmehr M; Shahbazi R; Sadreddini S; Baradaran B
    J Cell Physiol; 2019 Aug; 234(10):16861-16872. PubMed ID: 30779342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the microRNA-302/367 cluster in cancer therapy.
    Liu J; Wang Y; Ji P; Jin X
    Cancer Sci; 2020 Apr; 111(4):1065-1075. PubMed ID: 31957939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging roles of the polycistronic miR-106b∼25 cluster in cancer - A comprehensive review.
    Mehlich D; Garbicz F; Włodarski PK
    Biomed Pharmacother; 2018 Nov; 107():1183-1195. PubMed ID: 30257332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFL7: a unique angiogenic signaling factor in vascular development and disease.
    Nichol D; Stuhlmann H
    Blood; 2012 Feb; 119(6):1345-52. PubMed ID: 22160377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.